Pharmaceutical Industry Labelling

According to the WHO, more than 10% of drugs worldwide are counterfeit drugs, in developing countries even up to 30%. For the consumer or patient, counterfeit drugs pose a serious risk to their health. Counterfeit drugs are about the safety of the patient and, in the worst case, about survival. In addition to so-called lifestyle products, anti-cancer drugs, drugs for the treatment of cardiovascular problems, antibiotics and many other drugs are also affected by counterfeiting. EU citizens have a right to high quality, safe and effective medicines.In Directive 2001/83 / EC of the European Parliament and of the Council (4) provisions for the manufacture, import, placing on the market and wholesale distribution of medicinal products in the Union as well as the provisions for active substances have been laid down. The Falsified Medicines Directive entered into force on January 2, 2013. It includes measures to check the authenticity of drugs and to improve the quality of the ingredients. This increases the safety for the patient and consumer.